Skip to content
10-Q

Quarterly Report

VERACYTE, INC. VCYT

0001384101-25-000060

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 78.31M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $186.12M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $239.09M
Current Liabilities Q1 2025 · Mar 31, 2025 $75.13M
Current Liabilities Q1 2025 · Dec 31, 2024 $78.63M
Total Liabilities Q1 2025 · Mar 31, 2025 $120.48M
Total Liabilities Q1 2025 · Dec 31, 2024 $124.07M
Current Assets Q1 2025 · Mar 31, 2025 $383.15M
Current Assets Q1 2025 · Dec 31, 2024 $372.27M
Total Assets Q1 2025 · Mar 31, 2025 $1.32B
Total Assets Q1 2025 · Dec 31, 2024 $1.3B
Shares Diluted Q1 2025 · Mar 31, 2024 74.76M sh
Capex Q1 2025 · Mar 31, 2024 $2.13M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$8.97M
Stockholders Equity Q1 2025 · Mar 31, 2024 $1.12B
Stockholders Equity Q1 2025 · Dec 31, 2023 $1.04B
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.02
Eps Basic Q1 2025 · Mar 31, 2024 −$0.02
Sga Expense Q1 2025 · Mar 31, 2024 $26.21M
Rd Expense Q1 2025 · Mar 31, 2024 $15.97M
Net Income Q1 2025 · Mar 31, 2024 −$1.86M
Operating Income Q1 2025 · Mar 31, 2024 −$4.66M
Gross Profit Q1 2025 · Mar 31, 2024 $62.47M
Revenue Q1 2025 · Mar 31, 2024 $96.84M